Treatment • healthcare-in-europe.com

Hippocrates meets Medusa's head

By Dr J Larsen MD FRCR, Consultant Radiologist at Braunschweig Hospital, Germany

Dedicated to mammography

Hologic will be one of the biggest exhibitors at the 93rd Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA).

Screening

Switzerland - European experts presented and debates that controversial topic - breast cancer screening programmes - during a September symposium organised by Carestream Health.

World premiere at MEDICA

Over 15 million people are affected by strokes annually, and about five million of these (source: WHO 2004) are left with lasting damage.

SPAIN: Reduced radiotherapy procedures

Andalusía - Surgery and chemotherapy have overtaken radiotherapy for cancer treatments.

Sony launches new HD monitor for the healthcare sector

With the launch of its new LMD-2450MD monitor for use by medical professionals, Sony offers a its first high definition monitor that convinces with high image clarity and colour accuracy and therefore is ideal for endoscopic applications.

Development of potential Hepatitis C vaccine

The British Midlands' University of Nottingham discovered a possible vaccine for use in the treatment of Hepatits C. At the 161st. meeting of the Society for General Microbiology in Edinburgh, UK, a paper titled “Human Antibodies to Hepatits C Virus – Potential for Vaccine Design” was presented.

The therapeutic potential of adult stem cells in cardiovascular diseases

By Bodo E. Strauer (Düsseldorf, Germany) Russian summary and complete article in English.

Digital mammography: Higher detection rate for DCIS

The Vestfold County Study, performed by Norwegian researchers, is the first large scale study comparing the results of a particular full-field digital mammography system (FFDM) with that of conventional mammography. Einar Vigeland, Department of Radiology, Vestfold Hospital, Tønsberg, Norway, and his colleagues collected data over a period of two years.

E-SIRIUS Trial: Safety and efficacy of drug-eluting stents

Cordis Corporations' CYPHER stent is a Sirolimus-eluting coronary stent used for treatment of patients with coronary artery disease. The five-year results of the E-Sirius Trial show that in comparison to bare metal stents the CYPHER stent offers sustained clinical benefits.

Insulin capsules - a promising alternative to injections

Researchers from the Robert Gordon University in Aberdeen, UK, presented a study at The British Pharmaceutical Conference, held from 10th to 12th September, 2007, at Manchester Central, showing that a chemical coating is able to encapsulate and protect insulin against enzymes that usually break down the hormone in the gastrointestinal tract.

TWA predicts mortality in patients with normal ejection fraction

An increased TWA (T-wave alternans) is a significant indicator of all-cause and cardiovascular mortality, as well as of sudden cardiac death in patients with mostly normal ejection fraction, according to a recently published study by researchers led by Dr Tuomo Nieminen.

FRED® easyport

Cardiac infarction and cardiovascular failure are two of today's most frequent emergencies. SCHILLER's FRED® easyport® pocket is the only pocket defibrillator in the world.

Trial to raise awareness of gender and CVD

More women than men die of cardiovascular disease (CVD) every year, yet females receive only 33% of angioplasties, stents and bypass surgeries; 28% of implantable defibrillators, and 36% of open heart surgeries.

Atrial Fibrillation monitoring

The first implant of the Reveal XT, an insertable cardiac monitor made by US firm Medtronic, which recently received CE (Conformité Européenne) Mark, was carried out in June by Professor Karl-Heinz Kuck MD, at the Asklepios Klinik St. Georg in Hamburg, Germany.

Progenitor cell transfer for cardiac repair after

Progenitor cell transfer to repair the damaged heart has emerged as an innovative and promising recent development in cardiovascular medicine.

The therapeutic potential of adult stem cells in CVDs

Cardiac infarction is characterised by tissue ischaemia with loss of contractile heart muscle.

Cardiac resynchronisation therapy

Switzerland - A clinical trial of cardiac resynchronisation therapy (CRT) in patients with advanced heart failure and a narrow QRS complex

NEW BP-measuring device

A new blood pressure (BP) measuring device that provides, along with all the conventional cardiovascular parameters, the cardiac stroke volume, peripheral resistance and arterial augmentation, has been developed at the Austrian Research Centre (ARC), Vienna-Seibersdorf. The result of seven years' work by researchers, the device, named CardioMon, is now ready for sale.

Paediatric surgery: a major challenge

UK — A report on the care of young surgical patients has been launched by The Children's Surgical Forum, a body of representatives from the medical royal colleges, surgical specialist associations, Department of Health, Royal College of Nursing and the Royal College of Surgeons Patient Liaison Group.

A deeper view of wound infections

Launched last year, the Wound Infection Institute (WII), supported by Smith & Nephew Wound Management, now has a 130-strong membership, which include leading clinicians and scientists working to understand more about wound infections and their control.